These success, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two support the idea of focusing on ACKR3 as a novel way to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Conditions. It can also be https://conolidine-a-history-of-n43218.bligblogging.com/34307587/a-review-of-conolidine